ENTX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 12:54):

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs...

Stats
Today's Volume	24 164.00
Average Volume	231 788
Market Cap	70.96M
EPS	$0 ( 2024-03-29 )
Next earnings date	( $-0.0600 ) 2024-05-03
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.45
ATR14	$0.0100 (0.50%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-19	Yaacov-garbeli Dana	Buy	130 000	Stock Option (right to buy)
2024-04-19	Yaacov-garbeli Dana	Buy	30 151	Ordinary Shares, par value NIS 0.0000769 per share
2024-04-19	Galitzer Hillel	Buy	130 000	Stock Option (right to buy)
2024-04-19	Galitzer Hillel	Buy	30 151	Ordinary Shares, par value NIS 0.0000769 per share
2024-01-12	Taitel Haya	Buy	9 500	Ordinary Shares, par value NIS 0.0000769 per share

INSIDER POWER
100.00
Last 93 transactions
Buy: 4 653 836 \| Sell: 4 161 674

Volume Correlation

Long: 0.00 (neutral)

Short: -0.16 (neutral)

Signal:(50.654) Neutral

Entera Bio Ltd Correlation

10 Most Positive Correlations
TITN	0.854
TBLA	0.849
OPNT	0.84
OFIX	0.838
NAVI	0.835
LCAA	0.834
ATEC	0.831
ALSA	0.828
WDAY	0.827
GLLI	0.825

10 Most Negative Correlations
AVO	-0.847
BLIN	-0.845
GETVV	-0.84
GLUE	-0.839
SIDU	-0.837
ATAI	-0.824
BIMI	-0.819
CEG	-0.816
DRUG	-0.814
GPOR	-0.813

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Entera Bio Ltd Correlation - Currency/Commodity

-0.44
( neutral )

-0.27
( neutral )

0.00
( neutral )

-0.42
( neutral )

0.00
( neutral )

0.27
( neutral )

Entera Bio Ltd Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-56 000.00 (0.00 %)
EPS:	$-0.310

FY	2023
Revenue:	$0
Gross Profit:	$-56 000.00 (0.00 %)
EPS:	$-0.310

FY	2022
Revenue:	$134 000
Gross Profit:	$33 000.00 (24.63 %)
EPS:	$-0.450

FY	2021
Revenue:	$571 000
Gross Profit:	$198 000 (34.68 %)
EPS:	$0.425

Financial Reports:

No articles found.

Entera Bio Ltd

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.